Three patients who experienced central nervous system toxicity secondary to intraventricular therapy with cefazolin are described. On the basis of this experience it is recommended that cefazolin not be used for intraventricular antibiotic therapy in the treatment of shunt infections.
No takes yet. Share an insight, caveat, or question.
Manzella et al. (1988) studied this question.